Mutant TDP-43 and FUS Cause Age-Dependent Paralysis and Neurodegeneration in C. elegans
暂无分享,去创建一个
[1] N. Shneider,et al. The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span. , 2011, The Journal of clinical investigation.
[2] T. Kawano,et al. ALS mutations in FUS cause neuronal dysfunction and death in Caenorhabditis elegans by a dominant gain-of-function mechanism , 2011, Human molecular genetics.
[3] J. Julien,et al. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. , 2011, Brain : a journal of neurology.
[4] J. Haines,et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia , 2011, Nature.
[5] E. Brustein,et al. FUS and TARDBP but Not SOD1 Interact in Genetic Models of Amyotrophic Lateral Sclerosis , 2011, PLoS genetics.
[6] Pico Caroni,et al. Selective Neuronal Vulnerability in Neurodegenerative Diseases: from Stressor Thresholds to Degeneration , 2011, Neuron.
[7] Ji Han Kim,et al. A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43. , 2011, Human molecular genetics.
[8] Daniel F Tardiff,et al. A Yeast Model of FUS/TLS-Dependent Cytotoxicity , 2011, PLoS biology.
[9] O. Hardiman,et al. Amyotrophic lateral sclerosis , 2011, The Lancet.
[10] Jiou Wang,et al. TDP-43 neurotoxicity and protein aggregation modulated by heat shock factor and insulin/IGF-1 signaling. , 2011, Human molecular genetics.
[11] Nicole F. Liachko,et al. Phosphorylation Promotes Neurotoxicity in a Caenorhabditis elegans Model of TDP-43 Proteinopathy , 2010, The Journal of Neuroscience.
[12] I. Mackenzie,et al. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia , 2010, The Lancet Neurology.
[13] R. Tibbetts,et al. Amyotrophic Lateral Sclerosis-associated Proteins TDP-43 and FUS/TLS Function in a Common Biochemical Complex to Co-regulate HDAC6 mRNA* , 2010, The Journal of Biological Chemistry.
[14] H. Hutter,et al. Neurotoxic effects of TDP-43 overexpression in C. elegans. , 2010, Human molecular genetics.
[15] David M. Miller,et al. Coenzyme Q protects Caenorhabditis elegans GABA neurons from calcium-dependent degeneration , 2010, Proceedings of the National Academy of Sciences.
[16] Huilin Zhou,et al. ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS , 2010, Proceedings of the National Academy of Sciences.
[17] D. Cleveland,et al. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. , 2010, Human molecular genetics.
[18] G. Rouleau,et al. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. , 2010, Human molecular genetics.
[19] Jane Y. Wu,et al. A Drosophila model for TDP-43 proteinopathy , 2010, Proceedings of the National Academy of Sciences.
[20] G. Rouleau,et al. Genetics of motor neuron disorders: new insights into pathogenic mechanisms , 2009, Nature Reviews Genetics.
[21] V. Meininger,et al. Mutations in FUS cause FALS and SALS in French and French Canadian populations , 2009, Neurology.
[22] Xun Hu,et al. Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.
[23] D. Hall,et al. An ALS-Linked Mutant SOD1 Produces a Locomotor Defect Associated with Aggregation and Synaptic Dysfunction When Expressed in Neurons of Caenorhabditis elegans , 2009, PLoS genetics.
[24] B. Brais,et al. Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1. , 2008, Human molecular genetics.
[25] M. Kiernan,et al. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. , 2008, Brain : a journal of neurology.
[26] B. Kennedy,et al. Dietary restriction suppresses proteotoxicity and enhances longevity by an hsf‐1‐dependent mechanism in Caenorhabditis elegans , 2008, Aging cell.
[27] Michael Dybbs,et al. An RNAi Screen Identifies Genes that Regulate GABA Synapses , 2008, Neuron.
[28] B. McConkey,et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis , 2008, Nature Genetics.
[29] S. Lindquist,et al. A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity , 2008, Proceedings of the National Academy of Sciences.
[30] C. Lomen‐Hoerth,et al. Amyotrophic Lateral Sclerosis from Bench to Bedside , 2008, Seminars in neurology.
[31] J. Morris,et al. TDP‐43 A315T mutation in familial motor neuron disease , 2008, Annals of neurology.
[32] Xun Hu,et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.
[33] James J Collins,et al. The measurement and analysis of age-related changes in Caenorhabditis elegans. , 2008, WormBook : the online review of C. elegans biology.
[34] Randy D Blakely,et al. Vigorous Motor Activity in Caenorhabditis elegans Requires Efficient Clearance of Dopamine Mediated by Synaptic Localization of the Dopamine Transporter DAT-1 , 2007, The Journal of Neuroscience.
[35] Timothy R Mahoney,et al. Analysis of synaptic transmission in Caenorhabditis elegans using an aldicarb-sensitivity assay , 2006, Nature Protocols.
[36] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[37] D. Cleveland,et al. ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors , 2006, Neuron.
[38] Ehud Cohen,et al. Opposing Activities Protect Against Age-Onset Proteotoxicity , 2006, Science.
[39] Robert H. Brown,et al. Molecular biology of amyotrophic lateral sclerosis: insights from genetics , 2006, Nature Reviews Neuroscience.
[40] Thomas C. Evans,et al. Transformation and microinjection , 2006 .
[41] Theresa Stiernagle. Maintenance of C. elegans. , 2006, WormBook : the online review of C. elegans biology.
[42] Oliver Hobert,et al. A Conserved Postsynaptic Transmembrane Protein Affecting Neuromuscular Signaling in Caenorhabditis elegans , 2004, The Journal of Neuroscience.
[43] D. Hall,et al. Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans , 2002, Nature.
[44] G. Bernardi,et al. Pharmacologic reversal of cortical hyperexcitability in patients with ALS , 2000, Neurology.
[45] E. Jorgensen,et al. Identification and characterization of the vesicular GABA transporter , 1997, Nature.
[46] H. Horvitz,et al. The GABAergic nervous system of Caenorhabditis elegans , 1993, Nature.
[47] A. Ludolph,et al. Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.